Winblad. In addition to serving as the director of Karolinska Institute of Ageing Research Middle , KASPAC and the Swedish Brain Power Middle of Excellence, Prof. Winblad is presently in an array of research actions and he acts as a reviewer of study centers in Europe and the United States. Prof. Winblad provides more than 700 primary publications in gerontology, dementia and geriatrics research. UBC held a meeting to go over the Cognition Initiative, a multi-sponsor consortium to develop new measures appropriate for use as end points in international cognition trials. This initiative brings together international experts in cognition to build up new measures to expand the number of outcomes assessed and to address the necessity for improved measurement sensitivity at slight levels of impairment.CBS This early morning Healthwatch 23andMe CEO Anne Wojcicki talks genetic testing, her company’s goals Anne Wojcicki, 23andMe chief executive officer, joins the CBS TODAY co-hosts to discuss the type of information can be discovered throu. FDA regulators have been warning the business since 2010 that its test is considered a medical item and is subject to federal review. 23andMe started selling the check in 2007. FDA’s letter provides company 15 days to respond on paper with steps to improve the violation. Types of concern included tests for the BRCA gene variations associated with breast and ovarian tumor, or checks that look at whether folks are too sensitive to the blood thinner warfarin and could put their lives at risk by firmly taking it.